The metabolic vicious cycle in heart failure

[1] The effects of β1-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction -: A double-blind, placebo-controlled, positron-emission tomography study [J]. CIRCULATION, 2000, 102 (17) : 2070 - 2075

[2] IMPROVED HEMODYNAMIC FUNCTION AND MECHANICAL EFFICIENCY IN CONGESTIVE-HEART-FAILURE WITH SODIUM DICHLOROACETATE [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (07) : 1617 - 1624

[3] Etomoxir: a new approach to treatment of chronic heart failure [J]. LANCET, 2000, 356 (9242) : 1621 - 1622

[4] Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved [J]. CIRCULATION RESEARCH, 1996, 78 (03) : 482 - 491

[5] Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation [J]. CIRCULATION RESEARCH, 2004, 94 (09) : E78 - E84

[6] Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion [J]. CIRCULATION, 2004, 109 (08) : 962 - 965

[7] EFFECTS OF GLUCOSE AND FATTY-ACIDS ON MYOCARDIAL-ISCHEMIA AND ARRHYTHMIAS [J]. LANCET, 1994, 343 (8890) : 155 - 158

[8] RANDLE PJ, 1963, LANCET, V1, P785

[9] FATTY ACID AND GLUCOSE METABOLISM IN PERFUSED HEART [J]. NATURE, 1961, 189 (476) : 1018 - &

[10] Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions - Potential for pharmacological interventions [J]. CARDIOVASCULAR RESEARCH, 1997, 33 (02) : 243 - 257

[1] The effects of β1-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction -: A double-blind, placebo-controlled, positron-emission tomography study [J]. CIRCULATION, 2000, 102 (17) : 2070 - 2075

[2] IMPROVED HEMODYNAMIC FUNCTION AND MECHANICAL EFFICIENCY IN CONGESTIVE-HEART-FAILURE WITH SODIUM DICHLOROACETATE [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (07) : 1617 - 1624

[3] Etomoxir: a new approach to treatment of chronic heart failure [J]. LANCET, 2000, 356 (9242) : 1621 - 1622

[4] Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved [J]. CIRCULATION RESEARCH, 1996, 78 (03) : 482 - 491

[5] Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation [J]. CIRCULATION RESEARCH, 2004, 94 (09) : E78 - E84

[6] Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion [J]. CIRCULATION, 2004, 109 (08) : 962 - 965

[7] EFFECTS OF GLUCOSE AND FATTY-ACIDS ON MYOCARDIAL-ISCHEMIA AND ARRHYTHMIAS [J]. LANCET, 1994, 343 (8890) : 155 - 158

[8] RANDLE PJ, 1963, LANCET, V1, P785

[9] FATTY ACID AND GLUCOSE METABOLISM IN PERFUSED HEART [J]. NATURE, 1961, 189 (476) : 1018 - &

[10] Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions - Potential for pharmacological interventions [J]. CARDIOVASCULAR RESEARCH, 1997, 33 (02) : 243 - 257